Brussels - Delayed Quote EUR
BioSenic S.A. (BIOS.BR)
At close: November 1 at 5:21 PM GMT+1
Research Analysis
Revenue vs. Earnings
Revenue 1.35M
Earnings 247.5k
Analyst Price Targets
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | 1 | -- |
| Avg. Estimate | 0 | 0 | -0.05 | 0 |
| Low Estimate | 0 | 0 | -0.05 | 0 |
| High Estimate | 0 | 0 | -0.05 | 0 |
| Year Ago EPS | -- | -- | -0.21 | -0.05 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | -- | -- | -- | -- |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | -- |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | -- | -- | -- | -- |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | -0.05 | 0 |
| 7 Days Ago | 0 | 0 | -0.05 | 0 |
| 30 Days Ago | 0 | 0 | -0.05 | 0 |
| 60 Days Ago | 0 | 0 | -0.05 | 0 |
| 90 Days Ago | 0 | 0 | -0.05 | 0 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | BIOS.BR | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | -- | -- | -- | 5.10% |
| Next Qtr. | -- | -- | -- | 11.80% |
| Current Year | 76.20% | -- | -- | 2.10% |
| Next Year | -- | -- | -- | 12.30% |
| Next 5 Years (per annum) | -- | -- | -- | 11.68% |
| Past 5 Years (per annum) | -- | -- | -- | -- |
Related Tickers
CYAD.BR Celyad Oncology SA
0.2950
+5.73%
OXUR.BR Oxurion NV
0.3050
0.00%
ONWD.BR Onward Medical N.V.
5.12
-0.39%
3OS.BE Tempest Therapeutics Inc
0.8435
+0.42%
OBIMF ONDINE BIOMEDICAL INC
0.1100
0.00%
VF5.F Ondine Biomedical Inc.
0.0745
+4.93%
3OS.MU Tempest Therapeutics Inc
0.8462
+0.34%
6JH.SG IN8bio Inc
0.2540
0.00%
6C1.BE CytomX Therapeutics Inc
0.9515
+3.37%
6JH.F IN8bio, Inc.
0.2440
+5.17%